GLP-1 prevents neurodegeneration via upregulation of GLUT, thus reducing the potential for glutamate excitotoxicity
With 1 in 8 American adults about 32 million people saying they have tried a semaglutide during their lifetime and 6% currently taking one, according to a spring 2024 KFF Health Tracking Poll, it would be fair to say that this is no longer a trend
Most probably, the observation period of six months was too short to sensitively detect worsening in visual outcomes, including GCL volume loss, also proven by a recent study in which a delayed decline in visual field and GCL volume after 12 months was seen [39]
Diabetes Ther 11 , 19651982 (2020)
doi:10.1016/S2213-8587(21)00174-1 Ozempic tablets
Can you lose weight with semaglutide